Convergent genetic and expression data implicate immunity in Alzheimer's disease.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
De Jager, PL
St George-Hyslop, P
del Zompo, M
MC Cantwell, LB
de Bruijn, RFAG
van Duijn, CM
Van Broeckhoven, C
MetadataShow full item record
CitationAlzheimers Dement. 2015, 11 (6):658-71
AbstractLate-onset Alzheimer's disease (AD) is heritable with 20 genes showing genome-wide association in the International Genomics of Alzheimer's Project (IGAP). To identify the biology underlying the disease, we extended these genetic data in a pathway analysis.
The ALIGATOR and GSEA algorithms were used in the IGAP data to identify associated functional pathways and correlated gene expression networks in human brain.
ALIGATOR identified an excess of curated biological pathways showing enrichment of association. Enriched areas of biology included the immune response (P = 3.27 × 10(-12) after multiple testing correction for pathways), regulation of endocytosis (P = 1.31 × 10(-11)), cholesterol transport (P = 2.96 × 10(-9)), and proteasome-ubiquitin activity (P = 1.34 × 10(-6)). Correlated gene expression analysis identified four significant network modules, all related to the immune response (corrected P = .002-.05).
The immune response, regulation of endocytosis, cholesterol transport, and protein ubiquitination represent prime targets for AD therapeutics.
DescriptionTo access publisher's full text version of this article click on the hyperlink at the bottom of the page
RightsArchived with thanks to Alzheimer's & dementia : the journal of the Alzheimer's Association
- Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
- Authors: Hu YS, Xin J, Hu Y, Zhang L, Wang J
- Issue date: 2017 Apr 27
- Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
- Authors: Wang M, Roussos P, McKenzie A, Zhou X, Kajiwara Y, Brennand KJ, De Luca GC, Crary JF, Casaccia P, Buxbaum JD, Ehrlich M, Gandy S, Goate A, Katsel P, Schadt E, Haroutunian V, Zhang B
- Issue date: 2016 Nov 1
- Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.
- Authors: Talwar P, Silla Y, Grover S, Gupta M, Agarwal R, Kushwaha S, Kukreti R
- Issue date: 2014 Mar 15
- Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis.
- Authors: Lambert JC, Grenier-Boley B, Chouraki V, Heath S, Zelenika D, Fievet N, Hannequin D, Pasquier F, Hanon O, Brice A, Epelbaum J, Berr C, Dartigues JF, Tzourio C, Campion D, Lathrop M, Amouyel P
- Issue date: 2010
- Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
- Authors: Han MR, Schellenberg GD, Wang LS, Alzheimer's Disease Neuroimaging Initiative.
- Issue date: 2010 Oct 8